
This post begins an examination of the flawed concept of Patient Compliance, its implications, and possible remedies.
(May 17, 2009)The journey to an alternative to the current concept of compliance proceeds through the slough of despond where the flawed status quo is lamented, but the prospect of what could be is sighted.
(Jun 9, 2009)In an instances of serendipity, the AMA and I have each been independently engaged in changing the current perspective and policies on management of non-compliant patients.
(Jun 16, 2009)According to the Wall Street Journal article, UnitedHealth To Give Discounts For Adhering To Prescription [1] [1] http://online.wsj.com/article/BT-CO-20090827-712368.html?mg=com-wsj
(Sep 1, 2009)Where is the quintessential American compliance setting? Hint: Its not the doctor's office
(Sep 3, 2009)Include context-pertinent definitions of terms. Bringing down the current concept of patient compliance and replacing it with a functional set of principles is taking for-freaking-eve
(Sep 24, 2009)Differentiate unintentional from intentional noncompliance. This is the second in a series of posts offering steps to improve the study of and communication about patient compliance. <
(Sep 29, 2009)Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Kevin Appareti, Global Director Medical Science Liaison at Philips Healthcare, gives a short but useful interview on his company's approach to KOL engagement